Close Menu

NEW YORK — Genetic testing firm Prenetics said on Friday that it has acquired Oxsed, a University of Oxford spinout that was founded to develop and launch a rapid test for SARS-CoV-2.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.